1 min read
Bristol-Myers Squibb Q3 Estimates Show Revenue Up, EPS Down
The company is due to report before the U.S. market opens Thursday, Oct. 29; consensus calls for $12.73 billion in revenue.

Bristol-Myers Squibb is scheduled to release third-quarter results before Thursday's U.S. market open, with consensus estimates projecting revenue growth and a year-over-year drop in earnings per share.
The revenue estimate is $12.73 billion, up 4.2% from a year earlier. Earnings per share is projected at $1.22, down 25.2% year over year.